KOSDAQ · 214450 · Biotech & Pharma · ₩214450

PharmaResearch파마리서치

214450 · KOSDAQ · ₩214450 · 파마리서치

₩231,500▲ ₩2,000 (0.87%)End-of-day · Oct 27, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Advance Notice of Earnings Results Disclosure결산실적공시예고
Predicted impact: Low
Oct 28, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Oct 2, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Sep 1, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 7, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Aug 6, 2026Open on DART
Advance Notice of Earnings Results Disclosure결산실적공시예고Jul 14, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Jun 26, 2026Open on DART
Disclosure Related to Sustainability Management Report, etc. (Voluntary Disclosure)지속가능경영보고서등관련사항(자율공시)Jun 12, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Jun 9, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)May 8, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최May 6, 2026Open on DART
Advance Notice of Earnings Results Disclosure결산실적공시예고Apr 27, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 9, 2026Open on DART
Corporate value-up plan기업가치제고계획(자율공시)Mar 30, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
Audit report submitted감사보고서제출Mar 19, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 12, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
Amended: Shareholders' meeting called[기재정정]주주총회소집결의Mar 9, 2026Open on DART
Shareholders' meeting called주주총회소집결의Mar 6, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 12, 2026Open on DART
Investor relations (IR) event기업설명회(IR)개최Feb 10, 2026Open on DART
Cash dividend decision현금ㆍ현물배당결정Feb 4, 2026Open on DART
Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 4, 2026Open on DART
[Correction of Disclosure] Advance Notice of Earnings Results Announcement[기재정정]결산실적공시예고Jan 30, 2026Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 27, 2026Open on DART
Advance Notice of Earnings Results Disclosure결산실적공시예고Jan 26, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Jan 6, 2026Open on DART
Shareholder Register Closure for Cash/Stock Dividend (Record Date) Decision현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정Dec 16, 2025Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 16, 2025Open on DART
5%+ holding report주식등의대량보유상황보고서(약식)Dec 16, 2025Open on DART
Investor relations (IR) event기업설명회(IR)개최Nov 14, 2025Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Nov 12, 2025Open on DART
Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Nov 11, 2025Open on DART
Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 3, 2025Open on DART
Advance Notice of Earnings Results Disclosure결산실적공시예고Oct 24, 2025Open on DART
Not Designated as Unfaithful Disclosure Company (Designation Deferred)불성실공시법인미지정 (지정유예)Aug 21, 2025Open on DART
Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 8, 2025Open on DART
Advance Notice of Earnings Results Disclosure결산실적공시예고Aug 1, 2025Open on DART
Notice of Designation as Unfaithful Disclosure Company (Reversal of Disclosure)불성실공시법인지정예고 (공시번복)Jul 31, 2025Open on DART
Amended: Investor relations (IR) event[기재정정]기업설명회(IR)개최Jul 8, 2025Open on DART
Company split decision기타주요경영사항 (회사분할결정 철회)Jul 8, 2025Open on DART
Amended: Company split decision[기재정정]주요사항보고서(회사분할결정)Jul 8, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: PharmaResearch / 파마리서치 / 214450 / KRX:214450

Source: KRX statistical information